Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

ATXS Astria Therapeutics Inc

9,75

0,20 (2,09%)

Zuletzt aktualisiert: 19:54:44

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Astria Therapeutics (NASDAQ:ATXS)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Astria Therapeutics Charts.

Astria Therapeutics (NASDAQ:ATXS)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Astria Therapeutics Charts.

News Astria Therapeutics Inc

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Donnerstag 2 Mai 2024 (4 Tage vor) • Business Wire

Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
Dienstag 9 April 2024 (4 Wochen vor) • Business Wire

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mittwoch 3 April 2024 (1 Monat vor) • Business Wire

Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
Montag 25 März 2024 (1 Monat vor) • Business Wire

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dienstag 5 März 2024 (2 Monate vor) • Business Wire

Form 8-K - Current report
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Montag 4 März 2024 (2 Monate vor) • Business Wire

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting
Dienstag 20 Februar 2024 (3 Monate vor) • Business Wire

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Astria Therapeutics Inc News-Artikel

Energy Select Sector SPDR

JP Morgan Chase

Gold vs US Dollar

Deutsche Lufthansa

Deutsche Telekom

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen